98LBA Late Breaking - Results from the primary analysis of a 30 patient extension of the GATTO study, a phase Ib study combining the anti-MUC1 Gatipotuzumab (GAT) with the anti-EGFR Tomuzotuximab (TO) or Panitumumab in patients with refractory solid tumors
Saved in:
| Title: | 98LBA Late Breaking - Results from the primary analysis of a 30 patient extension of the GATTO study, a phase Ib study combining the anti-MUC1 Gatipotuzumab (GAT) with the anti-EGFR Tomuzotuximab (TO) or Panitumumab in patients with refractory solid tumors |
|---|---|
| Authors: | Macchini, M.1 (AUTHOR), Garralda, E.2 (AUTHOR), Fiedler, W.3 (AUTHOR), Del Conte, G.1 (AUTHOR), Rolling, C.3 (AUTHOR), Kebenko, M.3 (AUTHOR), Klinghammer, K.F.4 (AUTHOR), Ahrens-fath, I.5 (AUTHOR), Habel, B.5 (AUTHOR), Baumeister, H.5 (AUTHOR), Zurlo, A.5 (AUTHOR), Ochsenreiter, S.4 (AUTHOR) |
| Source: | European Journal of Cancer. 2020 Supplement 2, Vol. 138, pS5-S6. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 148120195 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 98LBA Late Breaking - Results from the primary analysis of a 30 patient extension of the GATTO study, a phase Ib study combining the anti-MUC1 Gatipotuzumab (GAT) with the anti-EGFR Tomuzotuximab (TO) or Panitumumab in patients with refractory solid tumors – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Macchini%2C+M%2E%22">Macchini, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garralda%2C+E%2E%22">Garralda, E.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fiedler%2C+W%2E%22">Fiedler, W.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Del+Conte%2C+G%2E%22">Del Conte, G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rolling%2C+C%2E%22">Rolling, C.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kebenko%2C+M%2E%22">Kebenko, M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Klinghammer%2C+K%2EF%2E%22">Klinghammer, K.F.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ahrens-fath%2C+I%2E%22">Ahrens-fath, I.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Habel%2C+B%2E%22">Habel, B.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baumeister%2C+H%2E%22">Baumeister, H.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zurlo%2C+A%2E%22">Zurlo, A.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ochsenreiter%2C+S%2E%22">Ochsenreiter, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Cancer%22">European Journal of Cancer</searchLink>. 2020 Supplement 2, Vol. 138, pS5-S6. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=148120195 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0959-8049(20)31083-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S5 Titles: – TitleFull: 98LBA Late Breaking - Results from the primary analysis of a 30 patient extension of the GATTO study, a phase Ib study combining the anti-MUC1 Gatipotuzumab (GAT) with the anti-EGFR Tomuzotuximab (TO) or Panitumumab in patients with refractory solid tumors Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Macchini, M. – PersonEntity: Name: NameFull: Garralda, E. – PersonEntity: Name: NameFull: Fiedler, W. – PersonEntity: Name: NameFull: Del Conte, G. – PersonEntity: Name: NameFull: Rolling, C. – PersonEntity: Name: NameFull: Kebenko, M. – PersonEntity: Name: NameFull: Klinghammer, K.F. – PersonEntity: Name: NameFull: Ahrens-fath, I. – PersonEntity: Name: NameFull: Habel, B. – PersonEntity: Name: NameFull: Baumeister, H. – PersonEntity: Name: NameFull: Zurlo, A. – PersonEntity: Name: NameFull: Ochsenreiter, S. IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 10 Text: 2020 Supplement 2 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09598049 Numbering: – Type: volume Value: 138 Titles: – TitleFull: European Journal of Cancer Type: main |
| ResultId | 1 |